default author photo

Kyung Hae Jung

University of Ulsan - Department of Oncology

Seoul

Korea, Republic of (South Korea)

  • University of Ulsan - Department of Oncology

SCHOLARLY PAPERS

6

DOWNLOADS

618

TOTAL CITATIONS

1

Scholarly Papers (6)

Actions:
Email selected abstracts
1.

Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer after Preoperative Chemoradiotherapy (ADORE): Long-Term Results of an Open-Label, Multicentre, Phase 2, Randomised Controlled Trial

Number of pages: 78 Posted: 08 Jan 2019
Yong Sang Hong, Sun Young Kim, Ji-Sung Lee, Byung-Ho Nam, Kyu-pyo Kim, Jeong Eun Kim, Young Suk Park, Joon Oh Park, Ji Yeon Baek, Tae-You Kim, Keun-Wook Lee, Joong Bae Ahn, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim, Seong Hyeon Yun, Jong Hoon Kim, Jin-hong Park, Hee Chul Park, Kyung Hae Jung and Tae Won Kim
University of Ulsan, University of Ulsan, University of Ulsan, College of Medicine, Asan Medical Center, Clinical Research Center, Institute of Advanced Clinical and Biomedical Research, University of Ulsan - Department of Oncology, University of Ulsan, Sungkyunkwan University - Department of Medicine, Sungkyunkwan University - Department of Medicine, National Cancer Center, Korea, Seoul National University - College of Medicine, Seoul National University - Department of Internal Medicine, Yonsei University, University of Ulsan, University of Ulsan, University of Ulsan, Sungkyunkwan University, University of Ulsan, University of Ulsan, Sungkyunkwan University, University of Ulsan - Department of Oncology and University of Ulsan - Department of Oncology
Downloads 163 (461,984)
Citation 1

Abstract:

Loading...

adjuvant chemotherapy; FOLFOX; 5-FU; rectal cancer; preoperative chemoradiotherapy

2.

Randomised Phase II Study of Palbociclib Plus Exemestane with GnRH Agonist Versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer

Number of pages: 90 Posted: 10 Jul 2019
Yeon Hee Park, Tae-Yong Kim, Gun Min Kim, Kyung Hae Jung, Seok Yun Kang, In Hae Park, Jee Hyun Kim, Kyoung Eun Lee, Hee Kyung Ahn, Moon Hee Lee, Hee-Jun Kim, Han Jo Kim, Jong In Lee, Su-Jin Koh, Ji-Yeon Kim, Kyung-Hun Lee, Joohyuk Sohn, Sung-Bae Kim, Jin Seok Ahn, Young-Hyuck Im and Seock-Ah Im
Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Oncology, Ajou University - School of Medicine, National Cancer Center, Korea, Seoul National University - Department of Internal Medicine, Ewha Womans University, Gachon University - Department of Internal Medicine, Inha University - Department of Internal Medicine, Chung-Ang University, College of Medicine, Department of Internal Medicine, Sungkyunkwan University - Division of Hematology-Oncology, Yonsei University - Department of Internal Medicine, University of Ulsan - Department of Hematology and Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Seoul National University - Department of Internal Medicine, Yonsei University - Yonsei Cancer Center, University of Ulsan - Department of Oncology, Sungkyunkwan University - Division of Hematology-Oncology, Sungkyunkwan University - Division of Hematology-Oncology and Seoul National University - Department of Internal Medicine
Downloads 119 (604,538)

Abstract:

Loading...

HR-positive, HER2-negative metastatic breast cancer; premenopausal women; palbociclib, exemestance, capecitabine

3.

Interaction of Chemotherapy and Ovarian Function Suppression on Menopausal Symptoms in Premenopausal Tamoxifen-Treated Breast Cancer Patients

Number of pages: 63 Posted: 05 Sep 2024
Young-Won Lee, Seunghee Baek, Jong Won Lee, Young-jin Lee, Tae-Kyung Robyn Yoo, Jisun Kim, Il Yong Chung, Beom Seok Ko, Hee Jeong Kim, Byung Ho Son, Kyung Hae Jung, Sung-Bae Kim, Saebyeol Lee and Yul Ha Min
Korea University - Korea University Anam Hospital, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Department of Oncology, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center and Kangwon National University
Downloads 109 (645,052)

Abstract:

Loading...

adjuvant endocrine therapy, Tamoxifen, Ovarian Function Suppression, menopausal symptoms, Breast Cancer

4.

Avelumab Alone or in Combination with Chemotherapy vs Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): A Randomised, Open-Label, Phase 3 Study

Number of pages: 52 Posted: 28 Oct 2020
Eric Pujade-Lauraine, Keiichi Fujiwara, Jonathan A. Ledermann, Amit M. Oza, Rebecca S. Kristeleit, Isabelle-Laure Ray-Coquard, Gary E. Richardson, Cristiana Sessa, Kan Yonemori, Susana Banerjee, Alexandra Leary, Anna V. Tinker, Kyung Hae Jung, Radoslaw Madry, Sang-Yoon Park, Sang-Yoon Park, Charles K. Anderson, Fabian Zohren, Ross A. Stewart, Caimiao Wei, Samuel S. Dychter and Bradley J. Monk
ARCAGY-GINECO, Saitama Medical University International Medical Center (SIMC), University College London - UCL Cancer Institute, University of Toronto - Princess Margaret Cancer Centre, University College London - UCL Cancer Institute, University of Claude Bernard Lyon 1 - Medical Oncology Department, Cabrini Hospital - Department of Medical Oncology, Ospedale San Giovanni - Oncology Institute of Southern Switzerland (IOSI), National Cancer Center Hospital - Department of Breast and Medical Oncology, Government of the United Kingdom - Royal Marsden NHS Foundation Trust, Université Paris XI Sud - Gustave Roussy Cancer Campus, BC Cancer, University of Ulsan - Department of Oncology, Poznan University of Medical Sciences - Department of Oncology, National Cancer Center - Center for Uterine CancerNational Cancer Center, Korea - Center for Gynecologic Cancer, Willamette Valley Cancer Institute and Research Center, Pfizer Oncology, Pfizer Oncology, Pfizer, Inc. - Pfizer Global Biometrics and Data Management, Pfizer Oncology and University of Arizona - College of Medicine, Arizona Oncology (US Oncology Network)
Downloads 101 (684,672)

Abstract:

Loading...

ovarian cancer, Avelumab, PD-L1, Phase 3, immune checkpoint inhibitor

5.

Effect of Early and Systematic Integrated Palliative Care in Patients with Advanced Cancer Who Failed Standard Chemotherapy: A Randomized Controlled Trial

Number of pages: 24 Posted: 08 Aug 2023
EunKyo Kang, Jung Hun Kang, Su-Jin Koh, Yu Jung Kim, Seyoung Seo, Jung Hoon Kim, Jaekyung Cheon, Eun Joo Kang, Eun-Kee Song, Eun Mi Nam, Ho-Suk Oh, Hye Jin Choi, Jung Hye Kwon, Woo Kyun Bae, Jung Eun Lee, Kyung Hae Jung and Young Ho Yun
Chinese Academy of Medical Sciences - National Cancer Center, Gyeongsang National University - Gyeongsang National University Hospital, University of Ulsan - Ulsan University Hospital, Seoul National University - Seoul National University Bundang Hospital, University of Ulsan - Asan Medical Center, Gyeongsang National University - Gyeongsang National University Hospital, CHA University - CHA Bundang Medical Center, Korea University - Department of Internal Medicine, Jeonbuk National University, Ewha Womans University, University of Ulsan, Yonsei University, Chungnam National University, Chonnam National University, Chungnam National University, University of Ulsan - Department of Oncology and Seoul National University - Department of Biomedical Science
Downloads 97 (720,278)

Abstract:

Loading...

early integrated palliative care, palliative care, advanced cancer

6.

Pathologic Complete Responses, Long-Term Outcomes, and Recurrence Patterns in HER2-Low vs HER2-Zero Breast Cancer after Neoadjuvant Chemotherapy

Number of pages: 22 Posted: 29 Jun 2022
Sora Kang, So Heun Lee, Hee Jin Lee, Hyehyun Jeong, Jae Ho Jeong, Jeong Eun Kim, Jin-Hee Ahn, Kyung Hae Jung, Gyungyub Gong, Hak Hee Kim, Saebyeol Lee, Jongwon Lee and Sung-Bae Kim
Chungnam National University - Chungnam National University Hospital, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Department of Oncology, University of Ulsan - Department of Oncology, University of Ulsan - Asan Medical Center, University of Ulsan - Department of Oncology, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center, University of Ulsan - Asan Medical Center and University of Ulsan - Asan Medical Center
Downloads 29 (1,332,057)

Abstract:

Loading...

Keywords: Breast cancer, HER2-low, HER2-zero, complete pathologic response, prognosis